13F Pro Quality Score

Not in ranked universe

Below size threshold

Quality rankings require at least $50M annual revenue or $250M total assets to filter out micro-caps and shell companies. This company reported $0.0M in revenue.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

TOXR Stock Analysis & AI Quality Score

AI stock analysis and institutional research for 21Shares XRP ETF (TOXR), a Financials sector company. TOXR is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least $50m annual revenue or $250m total assets to filter out micro-caps and shell companies. this company reported $0.0m in revenue. Top institutional holders of TOXR by reported 13-F value include SUSQUEHANNA INTERNATIONAL GROUP, LLP, JANE STREET GROUP,, Ronald Blue ,, based on the most recent SEC filings. TOXR trades on the CBOE exchange and files with the SEC under CIK 2028835. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate TOXR daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for 21Shares XRP ETF directly from SEC EDGAR.

Net Income

Q1 2026

$-52.3M

ROIC

Q1 2026

-36.8%

AI Insight: TOXR Financial Trends

21Shares XRP ETF equity base collapsed 49% from Q3 2025 to Q1 2026, driven by consecutive quarterly losses totaling $159M.

Equity declined from $280M (Q3 2025) to $142M (Q1 2026), a 49% contraction over two quarters.

Net losses of $107M (Q4 2025) and $52M (Q1 2026) eroded shareholder value sequentially.

Equity base now $142M with ongoing quarterly losses — sustainability of fund operations at risk if trend persists.

No operational cash flow, revenue, or operating income data available — limited visibility into fund performance drivers.

AI Insight: TOXR Ratio Trends

TOXR shows deeply negative ROE across consecutive quarters with no operational metrics available for trend assessment.

ROE deteriorated from -172.1% in Q4 2025 to -147.2% in Q1 2026, indicating persistent net losses relative to equity base.

Absence of operating margin, net profit margin, ROA, ROIC, and leverage data limits visibility into operational health and capital efficiency.

Consecutive quarters of triple-digit negative ROE suggest underlying losses; recovery trajectory unclear without earnings or cash flow data.

Get alerted when TOXR's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for 21Shares XRP ETF including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of TOXR

Put TOXR on your watchlist

Track score changes the day 21Shares XRP ETF files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is TOXR a good stock to buy?

13F Pro's AI-powered analysis of 21Shares XRP ETF (TOXR) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Financials sector (listed on CBOE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for TOXR are available on the TOXR stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own TOXR?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling TOXR. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of 21Shares XRP ETF's investment landscape.